298 related articles for article (PubMed ID: 36374097)
1. TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli.
Ou J; Elizalde P; Guo HB; Qin H; Tobe BTD; Choy JS
mBio; 2022 Dec; 13(6):e0219122. PubMed ID: 36374097
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis.
Jin M; Lu J; Chen Z; Nguyen SH; Mao L; Li J; Yuan Z; Guo J
Environ Int; 2018 Nov; 120():421-430. PubMed ID: 30125859
[TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
4. Combined exposure to non-antibiotic pharmaceutics and antibiotics in the gut synergistically promote the development of multi-drug-resistance in
Shi D; Hao H; Wei Z; Yang D; Yin J; Li H; Chen Z; Yang Z; Chen T; Zhou S; Wu H; Li J; Jin M
Gut Microbes; 2022; 14(1):2018901. PubMed ID: 35014598
[TBL] [Abstract][Full Text] [Related]
5. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
Langevin AM; El Meouche I; Dunlop MJ
mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
[TBL] [Abstract][Full Text] [Related]
6. Fitness trade-offs of multidrug efflux pumps in
Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL
Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137
[TBL] [Abstract][Full Text] [Related]
7. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
Piddock LJV
J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
[TBL] [Abstract][Full Text] [Related]
8. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
[TBL] [Abstract][Full Text] [Related]
9. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli.
Bohnert JA; Szymaniak-Vits M; Schuster S; Kern WV
J Antimicrob Chemother; 2011 Sep; 66(9):2057-60. PubMed ID: 21700628
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant exposure as a source of disinfectant resistance in waterborne bacteria.
Li H; Li X; Chen T; Yang Z; Shi D; Yin J; Yang D; Zhou S; Li J; Jin M
J Hazard Mater; 2023 Jun; 452():131371. PubMed ID: 37030229
[TBL] [Abstract][Full Text] [Related]
11. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
13. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
14. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli.
Sugawara E; Nikaido H
Antimicrob Agents Chemother; 2014 Dec; 58(12):7250-7. PubMed ID: 25246403
[TBL] [Abstract][Full Text] [Related]
15. Extreme Acid Modulates Fitness Trade-Offs of Multidrug Efflux Pumps MdtEF-TolC and AcrAB-TolC in Escherichia coli K-12.
Schaffner SH; Lee AV; Pham MTN; Kassaye BB; Li H; Tallada S; Lis C; Lang M; Liu Y; Ahmed N; Galbraith LG; Moore JP; Bischof KM; Menke CC; Slonczewski JL
Appl Environ Microbiol; 2021 Jul; 87(16):e0072421. PubMed ID: 34085861
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
Vediyappan G; Borisova T; Fralick JA
J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
[TBL] [Abstract][Full Text] [Related]
17. Transport Across Two Membrane Bilayers in E. coli by Efflux Pumps of Different Dimensions.
Yang L; Pandeya A; Li L; Ojo I; Li Z; Wei Y
J Mol Biol; 2022 Jan; 434(2):167376. PubMed ID: 34838522
[TBL] [Abstract][Full Text] [Related]
18. The Multidrug Efflux Regulator AcrR of Escherichia coli Responds to Exogenous and Endogenous Ligands To Regulate Efflux and Detoxification.
Harmon DE; Ruiz C
mSphere; 2022 Dec; 7(6):e0047422. PubMed ID: 36416552
[TBL] [Abstract][Full Text] [Related]
19. Stress Introduction Rate Alters the Benefit of AcrAB-TolC Efflux Pumps.
Langevin AM; Dunlop MJ
J Bacteriol; 2018 Jan; 200(1):. PubMed ID: 29038251
[TBL] [Abstract][Full Text] [Related]
20. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
